Last reviewed · How we verify
Diloderm (dichlorisone)
Diloderm (generic name: dichlorisone) is a dichlorisone drug. It is currently in unknown development.
Diloderm works by reducing inflammation in the skin through its anti-inflammatory properties.
Diloderm (dichlorisone) is a small molecule drug in the dichlorisone class. Its exact target and mechanism of action are unknown, but it is used to treat various skin conditions. The commercial status of Diloderm is unclear, and it may be patented or have generic manufacturers. Key safety considerations include potential skin irritation and allergic reactions. Further research is needed to fully understand the pharmacology of Diloderm.
At a glance
| Generic name | dichlorisone |
|---|---|
| Drug class | dichlorisone |
| Therapeutic area | Dermatology |
| Phase | unknown |
Mechanism of action
Imagine your skin has a fire burning inside it, causing redness and swelling. Diloderm helps put out that fire by reducing the chemicals that cause inflammation, which can help calm down the skin and reduce symptoms of conditions like eczema or psoriasis.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diloderm CI brief — competitive landscape report
- Diloderm updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Diloderm
What is Diloderm?
How does Diloderm work?
What is the generic name of Diloderm?
What drug class is Diloderm in?
What development phase is Diloderm in?
Related
- Drug class: All dichlorisone drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Dermatology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing